␣-Tocopherol transfer protein (␣-TTP), a cytosolic protein that specifically binds ␣-tocopherol, is known as a product of the causative gene in patients with ataxia that is associated with vitamin E deficiency. Targeted disruption of the ␣-TTP gene revealed that ␣-tocopherol concentration in the circulation was regulated by ␣-TTP expression levels. Male ␣-TTP ؊/؊ mice were fertile; however, placentas of pregnant ␣-TTP ؊/؊ females were severely impaired with marked reduction of labyrinthine trophoblasts, and the embryos died at mid-gestation even when fertilized eggs of ␣-TTP ؉/؉ mice were transferred into ␣-TTP ؊/؊ recipients. The use of excess ␣-tocopherol or a synthetic antioxidant (BO-653) dietary supplement by ␣-TTP ؊/؊ females prevented placental failure and allowed full-term pregnancies. In ␣-TTP ؉/؉ animals, ␣-TTP gene expression was observed in the uterus, and its level transiently increased after implantation (4.5 days postcoitum). Our results suggest that oxidative stress in the labyrinth region of the placenta is protected by vitamin E during development and that in addition to the hepatic ␣-TTP, which governs plasma ␣-tocopherol level, the uterine ␣-TTP may also play an important role in supplying this vitamin.Vitamin E (␣-tocopherol) is the most potent lipid-soluble antioxidant in biological membranes, where it contributes to membrane stability. Patients with ataxia and isolated vitamin E deficiency (AVED) 1 have low or undetectable serum vitamin E concentrations and exhibit neurological dysfunction and muscular weakness. It is now established that ␣-tocopherol transfer protein (␣-TTP), a cytosolic liver protein known to specifically bind to ␣-tocopherol (1), is defective in AVED patients (2), indicating that ␣-TTP is a major determinant of plasma ␣-tocopherol level. Although ␣-tocopherol was initially identified as an anti-sterility factor to prevent abortion (3), the mechanism of action and the molecules responsible for its antisterility effect remain unknown. One of the reasons for this is that vitamin E is difficult to deplete from tissues and requires elaborate manipulations to cause deficiency symptoms to occur in experimental animals. In this study, we established a mouse model lacking ␣-TTP by targeted mutagenesis. This animal model for human AVED patients is suitable for examination of the complex pathophysiology of diseases associated with vitamin E deficiency and/or caused by oxidative stress. Here we examined the role of ␣-TTP in pregnancy and embryogenesis using our new animal model.
MATERIALS AND METHODSGeneration of ␣-TTP Knockout Mice-An ␣-TTP targeting vector was constructed from an 8.8-kb ␣-TTP genome fragment encompassing exon 1. We inserted a fragment of PGK-neo cassette into the SmaI-SmaI site positioned 5Ј and 3Ј to exon 1 and flanked a 1.8-kb fragment of HSV-tk gene downstream of exon 2. AB2.2-Prime ES cells (Lexicon Genetics) or A3-1 ES (4) cells were transfected by electroporation with a linearized targeting vector. G418/gancyclovir-resistant clones were screened by PCR, and...